Safety, Tolerability and Efficacy of S-1226 in Cystic Fibrosis and Non CF Bronchiectasis

Recruiting

Phase 2

S-1226Safety, Tolerability and Efficacy of S-1226 in Cystic Fibrosis and Non CF Bronchiectasis

Sponsor:

SolAeroMed Inc.

Code:

NCT03903913

Conditions

Cystic Fibrosis

Bronchiectasis

Eligibility Criteria

Sex: All

Age: 14 - 50

Healthy Volunteers: Not accepted

Interventions

S-1226

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-06-04. This information was provided to ClinicalTrials.gov by SolAeroMed Inc. on 2021-06-16.